Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee

  1. Home

  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    Miscellaneous Rheumatic & Inflammatory Diseases Poster I
    Location: Hall F1
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0237: Monogenic autoinflammatory diseases and undefined autoinflammatory syndrome in Western Mediterranean adults: clinical, genetic, and therapeutic insights
    Location: Hall F1
    Abstract Poster Presenter: Alba Maria Torrat Noves, MD – Hospital Universitari i Politècnic La Fe de Valencia
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0238: Real-World Effectiveness of Mepolizumab on Gastrointestinal Involvement in Eosinophilic Granulomatosis with Polyangiitis and Hypereosinophilic Syndrome: A Multicenter Retrospective Study
    Location: Hall F1
    Abstract Poster Presenter: Alessia Gatti, MD – University of Brescia
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0239: Safety of Rilzabrutinib, a BTK Inhibitor, in Adult Patients with IgG4-related disease (IgG4-RD) in a 52-week Phase 2 Open-label Study
    Location: Hall F1
    Abstract Poster Presenter: Alireza Meysami – Henry Ford Health
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0240: Behçet’s Disease in a Diverse Urban Single-Center Cohort in the United States: HLA-B Alleles and Clinical Features
    Location: Hall F1
    Abstract Poster Presenter: Amir Razmjou, MD, MSc – UCLA / GLA-VA
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0241: Efficacy and Safety of JAK Inhibitors in Behçet's Syndrome: A Systematic Literature Review
    Location: Hall F1
    Abstract Poster Presenter: Bercemhan Sulu, MD (she/her/hers) – Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0242: Contemporary Recurrent Pericarditis Management – Real-world Evidence of Limited Cardiac Magnetic Resonance Imaging Prior to Initiating Rilonacept
    Location: Hall F1
    Abstract Poster Presenter: Brittany Weber, MD, PhD – Brigham and Women's Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0243: Epidemiology of adult-onset Systemic Autoinflammatory Diseases in a well-defined population from northern spain
    Location: Hall F1
    Abstract Poster Presenter: Carmen Lasa Teja, n/a – Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain.
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0244: Effectiveness and safety of Anifrolumab in Non-Systemic Cutaneous Lupus
    Location: Hall F1
    Abstract Poster Presenter: Carmen Lasa Teja, n/a – Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain.
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0245: Predictors of Arterial Stiffness in Connective Tissue Diseases: Insights from the Lupus Extended Autoimmune Phenotype (LEAP) Cohort Study
    Location: Hall F1
    Abstract Poster Presenter: Cristiana Sieiro Santos, MD – Centre for Musculoskeletal Research, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0246: Fracture Risk in Intestinal Autoimmune-mediated Diseases Patients: Clinical Insights from REMS
    Location: Hall F1
    Abstract Poster Presenter: Edmund MacLaughlin, MD – Rheumatology Associates of Delmarva
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0247: Use of Nintedanib in Patients with Progressive Pulmonary Fibrosis
    Location: Hall F1
    Abstract Poster Presenter: Elizabeth Volkmann, MD, MS – University of California, Los Angeles
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0248: Clinical and serological characteristics of anti-Ku autoantibodies in a Hispanic cohort
    Location: Hall F1
    Abstract Poster Presenter: Emmanuel Dominguez-Chapa, MS (he/him/his) – Universidad Autonoma de Nuevo Leon
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0249: Obesity as a possible confusion factor in the scleroderma pattern
    Location: Hall F1
    Abstract Poster Presenter: Eva Álvarez Andrés, PhD (she/her/hers) – Hospital Severo Ochoa ( Madrid)
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0250: Autoinflammatory diseases in adult patients. Spanish registry.
    Location: Hall F1
    Abstract Poster Presenter: Eztizen Labrador-Sánchez, MD – Hospital Universitario San Pedro
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0251: Impact of Mepolizumab on Idiopathic Hypereosinophilic Syndromes: Preliminary Analysis of a Monocentric Retrospective Cohort
    Location: Hall F1
    Abstract Poster Presenter: Jacopo Mora, MD – ASST Spedali Civili di Brescia
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0252: Capillaroscopic Signatures in Autoimmune Rheumatic Diseases: Unveiling Patterns in Systemic Sclerosis, Polyautoimmunity, and PAH
    Location: Hall F1
    Abstract Poster Presenter: Jairo Cajamarca, MD (he/him/his) – Fundacion universitaria de ciencia de la Salud
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0253: Ophthalmology Screening for Asymptomatic Uveitis in Sarcoidosis Patients: A Single-Center Investigation
    Location: Hall F1
    Abstract Poster Presenter: Justin Nguyen, MD – Virginia Commonwealth University Health Systems
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0254: Comparative Outcomes in MAGIC Syndrome versus Relapsing Polychondritis Alone: A Propensity-Matched Analysis
    Location: Hall F1
    Abstract Poster Presenter: Justin Riley Lam, MD – Jefferson Einstein Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0255: Clearing the Smoke: Association Between Cannabis Use and Autoimmune Disease Incidence in a Retrospective Cohort Analysis
    Location: Hall F1
    Abstract Poster Presenter: Justin Riley Lam, MD – Jefferson Einstein Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0256: The Role of Extracorporeal Membrane Oxygenation in Cardiopulmonary Dysfunction Due to Rheumatologic Diseases: A Systematic Review
    Location: Hall F1
    Abstract Poster Presenter: Kari Falaas, MD – University of Minnesota
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0257: Safety of Guselkumab in Inflammatory Bowel Disease Up to 1 Year: Integrated Safety Analysis of Phase 2 and 3 Studies in Crohn’s Disease and Ulcerative Colitis
    Location: Hall F1
    Abstract Poster Presenter: Karissa Lozenski, PhD – Johnson & Johnson
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0258: Performance characteristics of anti-Collagen II antibodies for diagnosing inflammatory and non-inflammatory diseases: a systematic review and meta-analysis
    Location: Hall F1
    Abstract Poster Presenter: Karyssa Stonick, BS – National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0259: Inhaled pirfenidone as an innovative therapeutic approach to treat autoimmune ILD and other forms of Progressive Pulmonary Fibrosis: Phase 2b Study Design
    Location: Hall F1
    Abstract Poster Presenter: Kristin B. Highland, MD, MS – Cleveland Clinic
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0260: Development of a Consensus Definition of VEXAS Flare for Use in Clinical Research
    Location: Hall F1
    Abstract Poster Presenter: Lachelle Weeks, MD, PhD – Dana-Farber Cancer Institute
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0261: Randomized Confirmatory Basket Trial: Performance Evaluation of a Simulated Application Example in Rare Disease Using Real World Data
    Location: Hall F1
    Abstract Poster Presenter: Linchen He, PhD – Novartis
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0262: Preclinical Characterization of ABB071 – a Humanized anti-CD180 Antibody that Modulates Multiple Pro-inflammatory Immune Pathways for the Treatment of Autoimmune and Inflammatory Disorders
    Location: Hall F1
    Abstract Poster Presenter: Margaret McDaniel, PhD – Abacus Bioscience
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0263: A Multicenter Retrospective Case Series of Patients with Susac Syndrome Treated with Rituximab
    Location: Hall F1
    Abstract Poster Presenter: Michelle Benjamin, MD – Stanford Health Care
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0264: Seeing Beyond the Eye: Subclinical Audio-Vestibular Involvement in Vogt-Koyanagi-Harada Disease
    Location: Hall F1
    Abstract Poster Presenter: Mohamed Tharwat Hegazy, MD, PhD, FACR (he/him/his) – Faculty of Medicine, Cairo University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0265: Influence of Menopausal Status on Coronary Artery Calcium Burden and Cardiovascular Computed Tomography Abnormalities in Inflammatory Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Mohammed Mohammed, MBChB (he/him/his) – University of Toronto
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0266: Chronic PPI Use Association with Development of Autoimmune Conditions: Retrospective Cohort Study
    Location: Hall F1
    Abstract Poster Presenter: Nanuka Tsibadze, MD – Jefferson Health - Einstein
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0267: Pharmacosurvellience study of FDA Adverse Event Reporting System (FAERS) events of Secukinumab and Guselkumab
    Location: Hall F1
    Abstract Poster Presenter: Nur Barlas, MD – Tulane University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0268: Multicenter study and literature review of JAK inhibitor treatment in refractory uveitis due to different immune-mediated inflammatory pathologies
    Location: Hall F1
    Abstract Poster Presenter: Nuria Barroso Garcia, -None-, MD – Hospital Regional Universitario Málaga
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0269: Clinical Landscape and Severity Markers of VEXAS Syndrome in a Spanish Cohort: Findings from VEXASSER Study Group
    Location: Hall F1
    Abstract Poster Presenter: Paula García-Escudero, MD – Hospital Universitario Álava
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0270: Diagnostic Challenge of IgG4-related Disease: Comparison Between ACR/EULAR, Umehara, and Okazaki Criteria
    Location: Hall F1
    Abstract Poster Presenter: Rafael Gálvez Sánchez, Sr, MD – Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain.
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0271: Clinical Presentation of Igg4-Related Disease. Multicenter Study and Literature Review
    Location: Hall F1
    Abstract Poster Presenter: Rafael Gálvez Sánchez, Sr, MD – Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain.
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0272: Ocular Involvement in Behçet’s Disease: Comparative Study of Two Classification Criteria in Clinical Practice
    Location: Hall F1
    Abstract Poster Presenter: Rafael Gálvez Sánchez, Sr, MD – Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain.
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0273: Effector CD8+ T cells and PD-1hi CXCL13hi CD4+ T cells contribute to recurrent immune checkpoint inhibitor mediated inflammatory arthritis
    Location: Hall F1
    Abstract Poster Presenter: Sang Kim, MD – Yale University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0274: Transplant-free survival in patients with systemic autoimmune rheumatic diseases and progressive pulmonary fibrosis in the ILD-PRO Registry
    Location: Hall F1
    Abstract Poster Presenter: Sonali Bracken, MD, PhD – Duke University Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0275: A Snapshot of Subcutaneous Infliximab Use in Inflammatory Rheumatic Diseases: A Multicenter Italian Study
    Location: Hall F1
    Abstract Poster Presenter: Stefano Gentileschi, MD – University Of Siena
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0276: Plasma Proteomic Profiling Identifies Inflammatory Proteins and Pathways Associated With Non-idiopathic and Idiopathic Retroperitoneal Fibrosis
    Location: Hall F1
    Abstract Poster Presenter: Thomas Pelowitz, BS – Mayo Clinic
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0277: A Phase 1, Randomized Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Single and Multiple Ascending Doses and Food Effects of BGB-45035, a Chimeric Degradation Activating Compound (CDAC), in Healthy Participants
    Location: Hall F1
    Abstract Poster Presenter: Vaibhav Mundra, MD – BeOne Medicines USA, Inc.
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0278: Classic and Clinically Amyopathic Dermatomyositis: Autoantibody Positivity
    Location: Hall F1
    Abstract Poster Presenter: Xiwei Yang, BA – Perelman School of Medicine, University of Pennsylvania
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0279: Assessment of Baseline igg4-rd Disease Characteristics and Impact upon Safety and Efficacy of Inebilizumab: Results from the MITIGATE Study
    Location: Hall F1
    Abstract Poster Presenter: Yoshiya Tanaka, MD, PhD – University of Occupational and Environmental Health, Japan
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0233: Differential Effects of GLP-1 Receptor Agonists versus SGLT2 Inhibitors on Hypoglycemia and Infection Risk in Diabetic Patients with Inflammatory Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Gurjot Singh, MD – Trihealth Good Samaritan Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0234: Use of Corneal Confocal Microscopy to Assess Small Fiber Neuropathy in Patients with Sarcoidosis
    Location: Hall F1
    Abstract Poster Presenter: Huzaefah Syed, MD, MPH, FACR – Virginia Commonwealth University Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0235: Mortality Trends due to Hypertension Related Deaths in Elderly Patients with Inflammatory Polyarthropathy: A CDC WONDER Analysis of 21 Years
    Location: Hall F1
    Abstract Poster Presenter: Rehan Ishaque, MBBS – Liaquat University of Medical Health & Sciences, Jamshoro
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0236: Safety and Efficacy of T Cell Engager Therapy in patients with refractory Autoimmune Disease
    Location: Hall F1
    Abstract Poster Presenter: Ricardo Grieshaber-Bouyer, MD, PhD – University Hospital Erlangen
  • Sunday, Oct 26th
    1:00 PM - 2:30 PM Central Time
    26S34: Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases I: Focus on Auto-inflammatory Diseases
    Location: W183A-C
    Abstract Moderator: Petros Efthimiou, MD, FACR – New York Rheumatology Care/Albert Einstein College of Medicine
    Abstract Moderator: Heather Gillespie, MD – Loma Linda University
     CE: 0.00
  • Sunday, Oct 26th
    1:00 PM - 1:15 PM Central Time
    0777: Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS-DAI)
    Location: W183A-C
    Presenting Author: Matthew Koster, MD, RhMSUS – Mayo Clinic
  • Sunday, Oct 26th
    1:15 PM - 1:30 PM Central Time
    0778: Clinical significance of non-infectious increased procalcitonin in Still’s disease: A predictor of macrophage activation syndrome
    Location: W183A-C
    Presenting Author: Erdem Bektas, MD – Istanbul University
  • Sunday, Oct 26th
    1:30 PM - 1:45 PM Central Time
    0779: Interim Results of a Randomized Placebo Controlled Study of IL-1 Inhibitor Goflikicept in Patients With Familial Mediterranean Fever
    Location: W183A-C
    Presenting Author: Serdal Ugurlu, MD – Istanbul University-Cerrahpasa, Department of Internal Medicine, Division of Rheumatology
  • Sunday, Oct 26th
    1:45 PM - 2:00 PM Central Time
    0780: Baseline Pharmacodynamic Markers and Response to Emapalumab in Children and Adults with Macrophage Activation Syndrome (MAS) in Still’s Disease: Results from a Pooled Analysis of Two Prospective Trials
    Location: W183A-C
    Presenting Author: Edward Behrens, MD – CHOP
  • Sunday, Oct 26th
    2:00 PM - 2:15 PM Central Time
    0781: Comprehensive mass cytometry analyses of disease-related cells in adult-onset Still's disease
    Location: W183A-C
    Presenting Author: Hiroto Yoshida, PhD – Chugai Pharmaceutical Co., Ltd.
  • Sunday, Oct 26th
    2:15 PM - 2:30 PM Central Time
    0782: Expansion of T bet Age-Associated B Cells Is Associated with Clinical Complications in Stills Disease
    Location: W183A-C
    Presenting Author: Krisztian Csomos, PhD – NIH/NIAMS
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    Miscellaneous Rheumatic & Inflammatory Diseases Poster II
    Location: Hall F1
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1147: Renal Manifestations in VEXAS Syndrome: A Systematic Review of Clinical Features, Pathology, and Outcomes
    Location: Hall F1
    Abstract Poster Presenter: Akhila Arya P V, MD (she/her/hers) – Yale University/Bridgeport Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1148: Interstitial Lung Disease in MCTD: A Retrospective Cohort Study at a Large Tertiary Medical Center
    Location: Hall F1
    Abstract Poster Presenter: Alana Haussmann, MD (she/her/hers) – University of California Los Angeles
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1149: Patient Symptom State Demonstrates Validity for the Assessment of Disease Activity and Patient-reported Outcomes in Adults with SAPHO and Chronic Nonbacterial Osteomyelitis – A Longitudinal Response Profile Analysis in The SAPHO-CNO Study
    Location: Hall F1
    Abstract Poster Presenter: Aleksander Lenert, MD;MS;FRCPC – University of Iowa
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1150: Impact of IL-17A on synovial fibroblast from subacromial bursae
    Location: Hall F1
    Abstract Poster Presenter: Andre Ramon, MD, PhD – Dijon University Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1151: A Comparison of Patients with Cardiac Sarcoidosis vs. Other Systemic Manifestations of Sarcoidosis: A Retrospective Cohort Study
    Location: Hall F1
    Abstract Poster Presenter: Chelsea Guan, MD – University Hospitals Cleveland Medical Center/Case Western Reserve University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1152: Cutaneous Panniculitis in Rheumatology: A Descriptive Cohort Study from a Multidisciplinary Experience
    Location: Hall F1
    Abstract Poster Presenter: Claudia Campos-Fabre, MD, MEd – Hospital Universitario La Paz
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1153: New Disease Classification in the Block? A 5-year Retrospective Review on Clinical Profiles and Mortality Outcomes of Patients Presenting with Hematoinflammatory Syndromes at a University Center in Florida
    Location: Hall F1
    Abstract Poster Presenter: Cristine Arcilla, MD (she/her/hers) – Lakeland Regional Health
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1154: Assessment of Damage Using the igg4-related Disease Damage Index
    Location: Hall F1
    Abstract Poster Presenter: Eduardo Martin-Nares, MD, MSc – Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1155: Zasocitinib (TAK-279), an Investigational, Oral, Allosteric, Selective TYK2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis: Efficacy Analysis by Baseline Characteristics from a Randomized Phase 2b Trial
    Location: Hall F1
    Abstract Poster Presenter: Ejim Mark, MD, MPH, MBA – Self Employed
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1156: Incidence and Prevalence of Interstitial Pneumonia with Autoimmune Features in a Population-Based Cohort
    Location: Hall F1
    Abstract Poster Presenter: Elena Joerns, MD, MPH – Mayo Clinic
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1157: Safety and Tolerability of a Recombinant Zoster Vaccine in Patients with Inflammatory Rheumatic Musculoskeletal Diseases: A Prospective Longitudinal Study over 12 Months
    Location: Hall F1
    Abstract Poster Presenter: Ella Steiner, -None- – Ruhr-University Bochum, Germany
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1158: Clinical and Genetic Features of CTLA-4 Haploinsufficiency : A Prospective Study in China
    Location: Hall F1
    Abstract Poster Presenter: guishan liu, PA – Peking Union Medical College Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1159: IL-18 Correlates with Pouchot Score and Inflammatory Biomarkers in Adult-Onset Still’s Disease: Insights From a Repeated Measures Study
    Location: Hall F1
    Abstract Poster Presenter: Hadeel Abdul-Rehman, BS – Hospital for Special Surgery
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1160: Plasma Adenosine Deaminase 2 as a Potential Disease Activity Biomarker for Sarcoidosis
    Location: Hall F1
    Abstract Poster Presenter: Jamie Lim, BS (she/her/hers) – Duke University School of Medicine
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1161: Comparative efficacy, safety and tolerability of antifibrotic therapies across systemic autoimmune diseases
    Location: Hall F1
    Abstract Poster Presenter: Javier Narvaez, PhD – Hospital Universitario de Bellvitge
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1162: Antineutrophil Cytoplasmic Antibody-associated Isolated Interstitial Lung Disease
    Location: Hall F1
    Abstract Poster Presenter: Javier Narvaez, PhD – Hospital Universitario de Bellvitge
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1163: Clinical and Biomarker Characteristics of Inebilizumab-Treated Participants Who Experienced an IgG4-RD Flare During the Phase 3 MITIGATE Trial
    Location: Hall F1
    Abstract Poster Presenter: John Stone, MD, MPH – Massachusetts General Hospital , Harvard Medical School
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1164: Effect of TNF Inhibitors on the Postprandial Glucose Homeostasis Molecules: Amylin, Gastric Inhibitory Polypeptide, and Pancreatic Polypeptide in Rheumatic Patients
    Location: Hall F1
    Abstract Poster Presenter: José Carlos García-Hernández, n/a (he/him/his) – Hospital Universitario de Canarias
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1165: Real-World On-Label Treatment Persistence Through 24 Months in Biologic-Naïve and Biologic-Experienced Patients with Psoriatic Arthritis: Comparison of Guselkumab versus Subcutaneous Tumor Necrosis Factor Inhibitors
    Location: Hall F1
    Abstract Poster Presenter: Joseph Merola, MD, MSc, FACR, FAAD – UT Southwestern Medical Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1166: Biomarkers Associated with Left Atrial Structure and Function in Individuals with Psoriasis
    Location: Hall F1
    Abstract Poster Presenter: Julie Borchsenius, MD (she/her/hers) – CTCPR / Center for translational cardiology and pragmatic research trials
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1167: Clinical Characteristics and Outcomes of igg4-related Disease Patients Who Chose Watchful Observation Without Treatment Intervention: A Single-center Study
    Location: Hall F1
    Abstract Poster Presenter: Kanako Chujo, MD – Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1168: Interstitial Lung Disease-Associated Antibody Testing and Positivity Rates in Systemic Autoimmune Rheumatic Diseases from a National Reference Laboratory
    Location: Hall F1
    Abstract Poster Presenter: Karis Lee, APRN – Labcorp
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1169: Periodontitis in neutropenic DADA2 patients
    Location: Hall F1
    Abstract Poster Presenter: Lorena Wilson, PhD, CRNP – National Institutes of Health
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1170: A20 Haploinsufficiency (HA20): TNFAIP3 Mutation Prevalence in a Clinically Compatible Cohort
    Location: Hall F1
    Abstract Poster Presenter: María Alonso de Francisco, MD – H. U. San Pedro
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1171: VEXAS Syndrome Under the Lens: A prospective analysis of temporal disease patterns, biomarker Dynamics, and therapeutic efficacy
    Location: Hall F1
    Abstract Poster Presenter: Marta López, MD – Complex Hospitalari Universitari Moisès Broggi
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1172: A Phase II, Single-site, Open-label Study of Zanubrutinib in Patients with igg4-related Disease
    Location: Hall F1
    Abstract Poster Presenter: Matthew Baker, MD, MS – Stanford University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1173: Prevalence of Coronary Artery Involvement in IgG4-Related Disease Detected by Non-Gated Cross-Sectional Imaging
    Location: Hall F1
    Abstract Poster Presenter: Matthew Baker, MD, MS – Stanford University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1174: High Prevalence of Autoimmunity in Rosai Dorfman Disease: A Multinational Study
    Location: Hall F1
    Abstract Poster Presenter: Mitali Sen, MD (she/her/hers) – University of Alabama at Birmingham
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1175: Secukinumab In Patients with Giant Cell Arteritis with Polymyalgia Rheumatica Symptoms: A Post Hoc Analysis of the Phase 2 TitAIN Study
    Location: Hall F1
    Abstract Poster Presenter: Nils Venhoff, MD – Department of Rheumatology and Clinical Immunology, Medical Center, Faculty of Medicine, University of Freiburg
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1176: VISIBLE Post-Inflammatory Pigmentation Journeys: Exploring the Impact of Pigmentation
    Location: Hall F1
    Abstract Poster Presenter: Oyediran Adelakun, MPH – Janssen Research & Development, LLC
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1177: Pregnancy Outcomes in Women with Familial Mediterranean Fever Treated with Anakinra: A Retrospective Study
    Location: Hall F1
    Abstract Poster Presenter: Ozgur Can Kilinc, n/a – Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1178: An International Modified Delphi Study on the Evolving Role of Janus Kinase Inhibitors (JAKi) in Rheumatic and Musculoskeletal Diseases (RMDs)
    Location: Hall F1
    Abstract Poster Presenter: Philip J. Mease, MD – Swedish Medical Center/Providence St. Joseph Health
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1179: Efficacy and Safety of Ruxolitinib in Adult Patients With Refractory Connective Tissue Disease-Associated Macrophage Activation Syndrome
    Location: Hall F1
    Abstract Poster Presenter: Qiong Fu, MD (she/her/hers) – Renji Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1180: Gender-Based Clinical Differences in Behçet’s Syndrome: Findings from a 24-Year Cohort in a Non-Endemic and Multiethnic Country
    Location: Hall F1
    Abstract Poster Presenter: Rafael Bassara Macedo, MD – Rheumatology Division - University of São Paulo
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1181: Clinical Relevance of Tumor Necrosis Factor Superfamily Cytokines
    Location: Hall F1
    Abstract Poster Presenter: Robert Corty, MD, PhD (he/him/his) – Vanderbilt University Medical Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1182: Cardiac Sarcoidosis in Black Patients: A Biopsy-Confirmed Cohort Study
    Location: Hall F1
    Abstract Poster Presenter: Roshan Subedi, MD – Georgetown/Washington Hospital Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1183: Risk of Inflammatory Bowel Disease in Psoriatic Arthritis Patients Treated with IL-17 Inhibitors
    Location: Hall F1
    Abstract Poster Presenter: Rusudan Tskitishvili, MD – Virtua Health
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1184: Does Blocking IL-17 Treat Recalcitrant Uveitis? Explorative Study on the Use of Ixekizumab to Manage Patients with Uveitis.
    Location: Hall F1
    Abstract Poster Presenter: Sergio Schwartzman, MD – Weill Cornell Medical Center, New York Presbyterian Hospital, and Hospital for Special Surgery
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1185: Pulmonary Arterial Hypertension in Adults with Still’s Disease: Another Pulmonary Manifestation Associated with HLA-DRB1*15
    Location: Hall F1
    Abstract Poster Presenter: STEPHANE MITROVIC, MD, MSc – Pitié-Salpêtrière Hospital, Rheumatology Department, APHP, Sorbonne University,
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1186: Increased Adoption of IL-1 Pathway Inhibition and the Steroid-sparing Paradigm Shift: Temporal Trends in Recurrent Pericarditis Treatment From the RESONANCE Patient Registry
    Location: Hall F1
    Abstract Poster Presenter: Sue Gibbons, MSN – Kiniksa
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1187: Myositis-Specific Antibody Profiles and Factors Associated With Rapidly Progressive Interstitial Lung Disease and Mortality in Antisynthetase Syndrome: A Systematic Review and Meta-Analysis
    Location: Hall F1
    Abstract Poster Presenter: Tulaton Sodsri, MD – Texas Tech University Health Sciences Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1188: Aortic Wall Shear Stress May Be a Protective Factor Against Development of Spinal Osteoproliferation
    Location: Hall F1
    Abstract Poster Presenter: Umut Kalyoncu, n/a – Division of Rheumatology, Department of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1189: Clinical Outcomes and Response to SARS-Cov-2 Infection and Vaccination in Ianalumab‑Treated Patients with Autoimmune Diseases
    Location: Hall F1
    Abstract Poster Presenter: Valerie Devauchelle, MD;PhD (she/her/hers) – UBO
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1190: IgG4-related disease with comorbid autoimmune diseases: a retrospective study from a large cohort
    Location: Hall F1
    Abstract Poster Presenter: Xinli Yang, MD – Peking Union Medical College
  • Monday, Oct 27th
    1:00 PM - 2:30 PM Central Time
    27M36: Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases II: Models and Mechanisms
    Location: S102
    Abstract Moderator: Jorge Gonzalez Chapa, MD, PhD – University of Washington
    Abstract Moderator: Lakshmi Jayaram, MD – Stanford University
     CE: 0.00
  • Monday, Oct 27th
    1:00 PM - 1:15 PM Central Time
    1662: Efficacy and Safety of Nerandomilast in Patients with Autoimmune Disease-Related Progressive Pulmonary Fibrosis: Subgroup Analysis of the FIBRONEER-ILD trial
    Location: S102
    Presenting Author: Anna-Maria Hoffmann-Vold, MD, PhD – Oslo University Hospital
  • Monday, Oct 27th
    1:15 PM - 1:30 PM Central Time
    1663: Tocilizumab for acute exacerbation of rheumatic disease-related interstitial lung disease: A prospective real-world study
    Location: S102
    Presenting Author: Wenwen Xu, MD (she/her/hers) – Shanghai Jiaotong University Affiliated Ruijin Hospital
  • Monday, Oct 27th
    1:30 PM - 1:45 PM Central Time
    1664: Cardiac Sarcoidosis Response to Steroid-Sparing Immunosuppression
    Location: S102
    Presenting Author: Matthew Baker, MD, MS – Stanford University
  • Monday, Oct 27th
    1:45 PM - 2:00 PM Central Time
    1665: Comparative Effectiveness of Biologic Versus Conventional Therapy in Uveitis with Systemic Rheumatic Diseases: Real-World Evidence from a Propensity-Matched Cohort
    Location: S102
    Presenting Author: Hanieh Akbari, MD – Jefferson Einstein Montgomery Medical Center
  • Monday, Oct 27th
    2:00 PM - 2:15 PM Central Time
    1666: Treatment with Rilzabrutinib was associated with Rapid and Sustained Reduction in Disease Activity in Patients with IgG4-RD Previously Treated or Naïve to B cell Depletion
    Location: S102
    Presenting Author: John Stone, MD, MPH – Massachusetts General Hospital , Harvard Medical School
  • Monday, Oct 27th
    2:15 PM - 2:30 PM Central Time
    1667: Recurrent or Incident Pericarditis With Concurrent Autoimmune Disease: Stable Control With Rilonacept Interleukin-1 Pathway Inhibition
    Location: S102
    Presenting Author: Zachary Daniel, MD (he/him/his) – Albany Medical College
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    Miscellaneous Rheumatic & Inflammatory Diseases Poster III
    Location: Hall F1
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2015: Clinical features of IgG4-related disease - a single centre experience
    Location: Hall F1
    Abstract Poster Presenter: Alojzija Hocevar, MD, PhD – University Medical Center Ljubljana
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2016: Effectiveness of Nintedanib combined with different DMARDs in joint and pulmonary domains of Rheumatoid Arthritis - Interstitial Lung Disease. National multicenter study of 74 patients
    Location: Hall F1
    Abstract Poster Presenter: Ana Serrano-Combarro, MD – Division of Rheumatology, Hospital Universitario Marques de Valdecilla, IDIVAL, Inmunopathology group, Santander
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2017: Baseline and 2-year Follow-up of Pulmonary Function Among CTD-ILD Subtypes
    Location: Hall F1
    Abstract Poster Presenter: Anchal Sabharwal, MD – Northwell Health
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2018: Investigating Epidemiology, Clinical associations, and Outcomes of Uveitis: A Retrospective Cohort Study
    Location: Hall F1
    Abstract Poster Presenter: Archit Srivastava, MD, MBBS – Boston Medical Center-Brighton/South, Boston University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2019: Incidence of Coronavirus Disease 2019 in Participants with IgG4-Related Disease Treated with Inebilizumab in the MITIGATE Study
    Location: Hall F1
    Abstract Poster Presenter: Arezou Khosroshahi, MD – Emory University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2020: Inebilizumab Efficacy and Safety in Patients with Common, Urgent, and Fibrotic Organ Manifestations of IgG4-RD: Subgroup Analyses from the MITIGATE Trial
    Location: Hall F1
    Abstract Poster Presenter: Arezou Khosroshahi, MD – Emory University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2021: Can Colchicine Be a Therapeutic Option for Patients with Ankylosing Spondylitis?
    Location: Hall F1
    Abstract Poster Presenter: Bahaddin Ates, n/a – Cerrahpasa Faculty of Medicine
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2022: Clinical Predictors of Macrophage Activation Syndrome and Treatment Outcomes in Adult-Onset Still’s Disease: A 24-Year Single-Center Experience
    Location: Hall F1
    Abstract Poster Presenter: Beste Acar, MD – Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2023: Isolated Anti-Ro52 Antibody Positivity Is Associated with Increased Cancer Risk and Distinct Malignancy Patterns: A Retrospective Cohort Study from a Single Tertiary Center
    Location: Hall F1
    Abstract Poster Presenter: CARMEN SECADA-GÓMEZ, MD – HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2024: Racial Disparities in Outcomes Among Patients With Neuromyelitis Optica: A Global Population-Based Study
    Location: Hall F1
    Abstract Poster Presenter: Chukwuemelie Okeke, MBBS – Maimonides Medical Center
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2025: Spectrum of Autoantibodies in CNS Demyelinating Diseases: Clinical, Laboratory and Imaging Associations
    Location: Hall F1
    Abstract Poster Presenter: Clio Mavragani, MD – National and Kapodistrian University of Athens
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2026: Clinical Features and Treatment Outcomes in Aseptic Abscess Syndrome: A Systematic Review of 104 Cases
    Location: Hall F1
    Abstract Poster Presenter: Eleni Papachristodoulou, MD – Mount Auburn Hospital, Harvard Medical School
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2028: Behçet’s Syndrome Beyond Endemic Borders: A 24-Year Longitudinal Analysis of Mortality in a Diverse South American Cohort
    Location: Hall F1
    Abstract Poster Presenter: Fabio Specian, Sr, MD – Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP)
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2029: Characteristics of a Historical Cohort of Adult Patients with Juvenile Idiopathic Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Francina Salabert Carreras, PhD – Hospital Germans Trias i Pujol
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2030: Krebs von den Lungen 6 levels (∆KL6) is a reliable marker of disease activity and response to therapy in CTD-ILD
    Location: Hall F1
    Abstract Poster Presenter: Fredeswinda Romero, MD (she/her/hers) – University Hospital Fundaci�n Jim�nez D�az\"\"
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2031: Management of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases: A Comparison of Rheumatologist and Pulmonologist Perspectives
    Location: Hall F1
    Abstract Poster Presenter: Genna Braverman, MD, MS – Hospital for Special Surgery
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2032: Validation of  systemic Juvenile Arthritis Disease Activity Score 10 (sJADAS 10) in adult patients with Still’s Disease
    Location: Hall F1
    Abstract Poster Presenter: Georgia-Savina Moysidou, MD, PhD – AP-HP
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2033: Complement Fragments are Deposited in the Submandibular Glands in IgG4-Related Disease
    Location: Hall F1
    Abstract Poster Presenter: Guy Katz, MD – Massachusetts General Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2034: Hidden Burden in Rheumatology: Cross-Sectional Study of Hearing Loss in Systemic Autoimmune Diseases
    Location: Hall F1
    Abstract Poster Presenter: Jairo Cajamarca, MD (he/him/his) – Fundacion universitaria de ciencia de la Salud
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2035: Interim Phase 1 Results for SPY002, a Novel Half-Life Extended Monoclonal Antibody Targeting TL1A, Suggest A Potential for Q3M or Q6M Maintenance Dosing for Rheumatologic Disease
    Location: Hall F1
    Abstract Poster Presenter: Joshua Friedman, MD, PhD – Spyre Therapeutics
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2036: JAK1 selective inhibitors versus pan-JAK inhibitors: comparative real-world study of drug retention in chronic inflammatory arthritis
    Location: Hall F1
    Abstract Poster Presenter: Leticia Leon, PhD, MSc (she/her/hers) – Hospital Clinico San Carlos
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2037: The Largest International Cohort Study of HA20 Reveals Novel Genetic Architecture and Age-Dependent Phenotypic Evolution
    Location: Hall F1
    Abstract Poster Presenter: Manuel Carpio Tumba, MD – University of Pittsburgh
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2038: Real-World Use of Dual Targeted Therapy in Rheumatic Disease: A Single-Center Case Series
    Location: Hall F1
    Abstract Poster Presenter: Marta Aguilar Zamora, MD (she/her/hers) – Hospital de Sagunto
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2039: To Hold or Not to Hold: Variability in Management of DMARDs in the Setting of Acute Infections - A Survey of Rheumatologists
    Location: Hall F1
    Abstract Poster Presenter: Mollie Gellman, MD – Montefiore Medical Center
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2040: Steroid Psychosis and Neuropsychiatric Symptoms induced by Corticosteroid Injection in Rheumatology Patients
    Location: Hall F1
    Abstract Poster Presenter: Morvarid Kavosh, MD – University of New Mexico
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2041: Evaluating Biologic Effectiveness in Co-Occurring Dermatologic and Rheumatic Disease: A Systematic Review
    Location: Hall F1
    Abstract Poster Presenter: Nashwah Memon, BS – Lake Erie College of Osteopathic Medicine
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2042: Safety and Effectiveness of the Use of Combined Therapy with bDMARDS and tsDMARDs in Immune-mediated Inflammatory Diseases
    Location: Hall F1
    Abstract Poster Presenter: Natalia López Juanes, MD – Hospital Universitario La Paz
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2043: Renal Outcomes of Long-term Canakinumab in Patients with Adult Familial Mediterranean Fever (FMF) and Biopsy-Confirmed AA Amyloidosis
    Location: Hall F1
    Abstract Poster Presenter: Omer Karadag, MD – Hacettepe University, Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2044: Infections and Associated Mortality in VEXAS Syndrome: A Systematic Review and Meta-Analysis
    Location: Hall F1
    Abstract Poster Presenter: Ozlem Arikan, MD – Istanbul Aydin University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2045: Malignancy in Behçet’s Syndrome: A 24-Year Cohort Study In a Non-Endemicand Multiethnic Country
    Location: Hall F1
    Abstract Poster Presenter: Pedro Cargnelutti de Araujo, Sr, MD – Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2046: Utilization of the All of Us Research Program to Study the Impact of Genetic Background on Autoinflammatory Diseases
    Location: Hall F1
    Abstract Poster Presenter: Qingping Yao, MD, PhD – Stony Brook University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2047: Trends in Lung Transplant Listing Outcomes in Connective Tissue Disease associated Interstitial Lung Disease (CTD-ILD) Across Two Decades
    Location: Hall F1
    Abstract Poster Presenter: Sambhawana Bhandari, MD – Washington University in St Louis
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2048: DDR2 auto-phosphorylation in patients with Warburg-Cinotti syndrome promotes differentiation of fibroblasts into myofibroblasts and expansion of immature B cells with antibody production.
    Location: Hall F1
    Abstract Poster Presenter: Sang Jin LEE, n/a – Kyungpook National University School of Medicine
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2049: Descriptive Analysis of a Cohort of Neurosarcoidosis Mimics
    Location: Hall F1
    Abstract Poster Presenter: Shivani Rangaswamy, MD – Duke University Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2050: Efficacy and Safety of Antifibrotic Therapy in Autoimmune–Associated Interstitial Lung Disease: A Meta-Analysis
    Location: Hall F1
    Abstract Poster Presenter: Sri Laxmi Priya Sunkara, MD (she/her/hers) – White river medical center
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2051: Clinical Burden of Illness Among Patients with Immunoglobulin-G4-Related Disease in the United States
    Location: Hall F1
    Abstract Poster Presenter: Sushmitha Inguva, PhD – Amgen Inc.
  • Wednesday, Oct 29th
    11:30 AM - 1:00 PM Central Time
    29W19: Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases III: End Organ Focus on Heart, Lung and Eye
    Location: W190A-B
    Abstract Moderator: Lesley Ann Saketkoo, MD, MPH – University Medical Center - Comprehensive Pulmonary Hypertension Center and ILD Clinic Programs // New Orleans Scleroderma and Sarcoidosis Patient Care & Research Centeris
    Abstract Moderator: Carrie Richardson, MD, MHS – Northwestern University
     CE: 0.00
  • Wednesday, Oct 29th
    11:30 AM - 11:45 AM Central Time
    2663: PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome
    Location: W190A-B
    Presenting Author: David Beck, MD, PhD – New York University
  • Wednesday, Oct 29th
    11:45 AM - 12:00 PM Central Time
    2664: Neutrophil-to-Lymphocyte Ratio (NLR) as a Clinically Accessible Marker for Interferon Signatures in Autoimmune Diseases
    Location: W190A-B
    Presenting Author: Yoshinobu Koyama, MD, PhD – Japanese Red Cross Okayama Hospital
  • Wednesday, Oct 29th
    12:00 PM - 12:15 PM Central Time
    2665: Preexisting Antibodies Against Vaccine Antigens Are Preserved In Patients With Systemic Lupus Erythematosus and Sjögren’s Disease Upon Ianalumab Treatment While Autoantibodies Decline
    Location: W190A-B
    Presenting Author: Thomas Grader-Beck, MD – Johns Hopkins
  • Wednesday, Oct 29th
    12:15 PM - 12:30 PM Central Time
    2666: Rare TNFAIP3 Hypomorphic Variants are a Massively Underestimated Driver of Human Autoinflammatory Disease
    Location: W190A-B
    Presenting Author: Danica Lee, BA – University of Pittsburgh School of Medicine
  • Wednesday, Oct 29th
    12:30 PM - 12:45 PM Central Time
    2667: Amyloidosis Secondary to Familial Mediterranean Fever: Machine Learning Based Prediction Models
    Location: W190A-B
    Presenting Author: Berkay Aktaş, MD – Cerrahpasa Faculty of Medicine
  • Wednesday, Oct 29th
    12:45 PM - 1:00 PM Central Time
    2668: CD14⁺ Myeloid Cells Mediate UVB Photosensitivity in Autoimmune Skin Disease via a Spatially Resolved Inflammatory Circuit
    Location: W190A-B
    Presenting Author: Mehdi Rashighi, MD – UMass Chan Medical School